The DOI matches its Crossref record; 102 of the 102 references it cites were found in a registry or an index.
Me, myself, bye: regional alterations in glutamate and the experience of ego dissolution with psilocybin
Open accessAbstract
There is growing interest in the therapeutic utility of psychedelic substances, like psilocybin, for disorders characterized by distortions of the self-experience, like depression. Accumulating preclinical evidence emphasizes the role of the glutamate system in the acute action of the drug on brain and behavior; however this has never been tested in humans. Following a double-blind, placebo-controlled, parallel group design, we utilized an ultra-high field multimodal brain imaging approach and demonstrated that psilocybin (0.17 mg/kg) induced region-dependent alterations in glutamate, which predicted distortions in the subjective experience of one’s self (ego dissolution). Whereas higher levels of medial prefrontal cortical glutamate were associated with negatively experienced ego dissolution, lower levels in hippocampal glutamate were associated with positively experienced ego dissolution. Such findings provide further insights into the underlying neurobiological mechanisms of the psychedelic, as well as the baseline, state. Importantly, they may also provide a neurochemical basis for therapeutic effects as witnessed in ongoing clinical trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures

![Fig. 2 Raincloud plots displaying metabolite concentrations in the mPFC and the hippocampus, which demonstrated significant differences between treatment groups. a glutamate in the mPFC, b NAA in the mPFC, c glutamate in the hippocampus, d GABA in the mPFC. The plot consists of a probability density plot, a boxplot, and raw data points. In the boxplot, the line dividing the box represents the median of the data, the ends represent the upper/lower quartiles, and the extreme lines represent the highest and lowest values excluding outliers. The code for raincloud plot visualization has been adapted from Allen et al. [99].](/paper-figures/c830fa3cb891411e99e26af3030e1d35/me-myself-bye-regional-alterations-in-glutamate-and-the-experience-of-ego-figure-2.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Consequently, in this state, individuals may more readily engage with their cognitive beliefs and emotional states with enhanced detachment and decentration, potentially leading to therapeutic outcomes [42, 43].”
From Mindfulness meditation and psychedelics: potential synergies and commonalities (2023) · cites this paper as [42]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The potential of classic psychedelics to alter glutamate in the human cortex, albeit in a region-dependent manner, has been demonstrated (92).”
From Psychedelics and Neuroplasticity: A Systematic Review Unraveling the Biological Underpinnings of Psychedelics. (2021) · cites this paper as [92]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A default mode of brain function
Raichle, M. E., MacLeod, A. M., Snyder, A. Z., Powers, W. J., Gusnard, D. A., & Shulman, G. L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.2.676 · Cited by 12,190
Correspondence of the brain's functional architecture during activation and rest
Smith, S. M., Fox, P. T., Miller, K. L., Glahn, D. C., Fox, P. M., Mackay, C. E., Filippini, N., Watkins, K. E., Toro, R., Laird, A. R., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905267106 · Cited by 5,150
Conn : A Functional Connectivity Toolbox for Correlated and Anticorrelated Brain Networks
Whitfield-Gabrieli, S., & Nieto-Castanon, A. (2012) · Brain Connectivity · doi:10.1089/brain.2012.0073 · Cited by 4,885
A method for making group inferences from functional MRI data using independent component analysis
Calhoun, V. D., Adali, T., Pearlson, G. D., & Pekar, J. J. (2001) · Human Brain Mapping · doi:10.1002/hbm.1048 · Cited by 2,994
Griffiths, R. R., Johnson, M. W., Carducci, M. A., Umbricht, A., Richards, W. A., Richards, B. D., Cosimano, M. P., & Klinedinst, M. A. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116675513 · Cited by 2,201 · cited 2×
“A paradoxical effect of serotonergic psychedelics is that acutely they have been found to increase feelings of anxiety [6, 78], whereas clinical trials with psychedelic drugs suggest long-term anxiety relief in patients [11, 12, 14].”
BackgroundNichols, D. E. (2016) · Pharmacological Reviews · doi:10.1124/pr.115.011478 · Cited by 1,762
Griffiths, R. R., Richards, W. A., McCann, U., & Jesse, R. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0457-5 · Cited by 1,684
Carhart-Harris, R. L., Bolstridge, M., Rucker, J., Day, C. M. J., Erritzoe, D., Kaelen, M., Bloomfield, M., Rickard, J. A., Forbes, B., Feilding, A., et al. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(16)30065-7 · Cited by 1,540
Self-citationBunney, W. E., Hippius, H., Laakmann, G., & Schmauß, M. (1990) · Springer eBooks · doi:10.1007/978-3-642-74034-3 · Cited by 1,523
A Baseline for the Multivariate Comparison of Resting-State Networks
Allen, E. A., Erhardt, E. B., Damaraju, E., Gruner, W. E., Segall, J. M., Silva, R. F., Havlíček, M., Rachakonda, S., Fries, J. F., Kalyanam, R., et al. (2011) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2011.00002 · Cited by 1,329
Cited by
Sorted by citations
Items 201–258 of 258
Allen, J., Jupp, B., Baker, T. L., Haskali, M. B., Brkljača, R., Plummer, Z., Sun, M., Brand, J., Christie, B. R., Debert, C. T., et al. (2026) · Cell Reports Medicine · doi:10.1016/j.xcrm.2026.102867 · Cited by 2
Lyon, A. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780198843757.003.0001 · Cited by 1
Lyon, A. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780198843757.003.0005 · Cited by 1
The influence of psilocybin on subconscious and conscious emotional learning
Casanova, A. F., Ort, A., Smallridge, J. W., Preller, K. H., Seifritz, E., & Vollenweider, F. X. (2024) · iScience · doi:10.1016/j.isci.2024.110034 · Cited by 2
Singleton, S. P., & Kuceyeski, A. F. (2024) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2024.05.003 · Cited by 1
Psilocybin Therapy for Major Depressive Disorder: A Systematic Review
Venugopal, K. (2023) · Undergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal · doi:10.26685/urncst.489 · Cited by 1
Poulin, J. M., Bigford, G. E., Lanctôt, K. L., Giacobbe, P., Schaffer, A., Sinyor, M., Rabin, J. S., Masellis, M., Singnurkar, A., Pople, C. B., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-3474764/v1 · Cited by 1
Ivan, V. E., Tomàs‐Cuesta, D. P., Esteves, I. M., Luczak, A., Mohajerani, M. H., McNaughton, B. L., & Gruber, A. J. (2024) · doi:10.22541/au.171378690.00112411/v1 · Cited by 1
Psilocybin Therapy for Depression and Anxiety in Parkinson's Disease: An Open-Label Pilot TrialPreprint
Bradley, E., Sakai, K., Fernandes‐Osterhold, G., Szigeti, B., Ludwig, C., Ostrem, J. L., Tanner, C. M., Bock, M., Llerena, K., Finley, P. R., et al. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4871260 · Cited by 1
Psilocybin Modulates TPJ Effective Connectivity during Out-of-Body ExperiencesPreprint
Stoliker, D., Bernasconi, F., Blanke, O., & Razi, A. (2025) · medRxiv · doi:10.1101/2025.06.24.25330245 · Cited by 2
Martin, H. M., Cofré, R., & Alain Destexhe, A. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.20.683366 · Cited by 1
Chung, D.-Y. (2020) · Journal of Behavioral and Brain Science · doi:10.4236/jbbs.2020.1011030
Online Assignments at Kilimanjaro Christian Medical University College during the COVID-19 Pandemic
Stienen, G. J. M., Ibrahim, G., Luzinge, H., Mteta, A. K., Msuya, L. J., & Bartlett, J. A. (2022) · The Biophysicist · doi:10.35459/tbp.2021.000194
Psilocybe mexicana R. Heim – Mexikanischer Kahlkopf
Kuhn, A., & Melzig, M. F. (2022) · Zeitschrift für Phytotherapie · doi:10.1055/a-1540-9907
The good, the bad, and the intoxicated
Mason, N. L. (2021) · Research Publications (Maastricht University) · doi:10.26481/dis.20210608nm
Self-citationEt psykoanalytisk og et postmoderne perspektiv på selv/egoopløsning i en psykedelisk kontekstPreprint
Andersen, S. (2023) · PsyArXiv (OSF Preprints) · doi:10.31234/osf.io/f26ce
Lyon, A. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780198843757.003.0010
Lyon, A. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780198843757.003.0011
Lyon, A. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780198843757.003.0008
Lyon, A. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780198843757.003.0006
Lyon, A. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780198843757.003.0012
(2023) · Oxford University Press eBooks · doi:10.1093/oso/9780198843757.002.0006
Lyon, A. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780198843757.003.0007
(2023) · Oxford University Press eBooks · doi:10.1093/oso/9780198843757.002.0003
Lyon, A. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780198843757.003.0004
What Is Psychedelic Experience?
Lyon, A. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780198843757.003.0002
(2023) · Oxford University Press eBooks · doi:10.1093/oso/9780198843757.002.0005
Lyon, A. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780198843757.003.0003
Elder, H. J., Walentiny, D. M., & Beardsley, P. M. (2023) · SSRN Electronic Journal · doi:10.2139/ssrn.4658637
Ketamine and Psilocybin Differentially Impact Sensory Learning During the Mismatch NegativityPreprint
Allohverdi, S. G., Soltanzadeh, M., Schmidt, A., Charlton, C. E., Hauke, D. J., Karvelis, P., Vollenweider, F. X., & Diaconescu, A. O. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.21203/rs.3.rs-4492873/v1
Psychedelic Ego Dissolution: A Philosophical and Qualitative AnalysisPreprint
Day, J. K., & Zahavi, D. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5144068
Elder, H., Walentiny, D. M., & Beardsley, P. M. (2024) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2025.174004
Goldway, N., Hendler, T., Jalon, I., Pasternak, Y., Sar-El, R., Mirelman, D., Sarna, N., Green, N., Agbaria, Y., & Sharon, H. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.07.25.666594
Altered State of Consciousness
Habeeb, S. (2025) · Springer eBooks · doi:10.1007/978-3-031-38971-9_18-1
McConnell, P., Raffety, J., Li, A., Steinberg, E., Rahim, S., Valtierra, C., Gazzaley, A. H., Carhart-Harris, R. L., & Pasquini, L. (2025) · Research Square · doi:10.21203/rs.3.rs-7625999/v1
Unmixing the psychedelic connectome: Brain network traits of psilocybin
Bhavaraju, K. P., Mason, N. L., Mallaroni, P., Heinke, D. G., Toennes, S. W., Ramaekers, J. G., & Amico, E. (2026) · Network Neuroscience · doi:10.1162/netn.a.594
Self-citationVoyages dans la conscience : des pratiques chamaniques aux techniques contemporaines de transe
Dellanoce, F., Artru, E., Breton, A., & Lombardi, D. (2026) · L Évolution Psychiatrique · doi:10.1016/j.evopsy.2026.01.004
Psilocin fosters neuroplasticity in iPSC-derived human cortical neuronsPreprint
Schmidt, M., Hoffrichter, A., Davoudi, M., Horschitz, S., Lau, T., Meinhardt, M. W., Spanagel, R., Ladewig, J., Köhr, G., & Koch, P. J. (2026) · eLife · doi:10.7554/elife.104006.2
Magnani, L., Ghirotto, L., Fesce, F., Re, T., Tanzi, S., Amerio, A., & Costanza, A. (2026) · BMJ Supportive & Palliative Care · doi:10.1136/spcare-2025-005689
Gubser, L. P., Trippel, A., Zoelch, N., Engeli, E., & Herdener, M. (2026) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2026.111842
Le LSD revisité : mécanismes d’action et potentiel en santé mentale
Bouloufa, A., Delcourte, S., Delannay, T., & Haddjeri, N. (2026) · L Encéphale · doi:10.1016/j.encep.2026.02.008
Bertollo, A. G., Wippel, V. A., Mingoti, M. E. D., Prediger, R. D., & Ignácio, Z. M. (2026) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2026.179036
Hampsey, E., Martin, K., Kalfas, M., Benson, L. E., Wihlborg, S., Jelen, L. A., Young, A. H., & Rucker, J. (2026) · Journal of Psychopharmacology · doi:10.1177/02698811261453938
Computational spirits: a neuroscientific account of psychedelic entity encounters
Mago, J., Deane, G., Sandved-Smith, L., Safron, A., Timmermann, C., Ramstead, M. J. D., Dupuis, D., Carhart-Harris, R. L., Greenway, K. T., & Lifshitz, M. (2026) · Neuroscience of Consciousness · doi:10.1093/nc/niaf069
Psychedelics: Historical Context, Emerging Science, and Future Clinical Frontiers
Janardan, V., Khanna, A., Prakash, O., Debbarma, A., & Mathur, S. (2026) · Journal of Mental Health Disorders · doi:10.33696/mentalhealth.6.068
Trance practice and well-being measures: the case of Auto-Induced Cognitive TrancePreprint
Fernandez, A., Foncelle, A., Meunier, H., Revillet, F., & Breton, A. (2026) · medRxiv · doi:10.64898/2026.07.15.26358125
Cellular mechanisms of serotonergic psychedelics - apical hypercontextualisation
Kaup, K., Jiménez, J. H., & Aru, J. (2026) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2026.106876
Who am I? Self-inquiry as a neurophenomenological approach to consciousness
Tirumalasetti, S. (2026) · Frontiers in Psychology · doi:10.3389/fpsyg.2026.1951193
Jones, G. H., Gilbert, J. R., Johnston, J. N., Akula, N., Schulmann, A., Arakelian, M. H., Peng, S., Yuan, P., Winful, E. A., Yavi, M., et al. (2026) · Molecular Psychiatry · doi:10.1038/s41380-026-03777-z
Neurobiologie der Psychedelika
Schmitz, C., & Adolphi, H. (2026) · Elsevier eBooks · doi:10.1016/b978-3-437-21293-2.00004-6
O'Shea, A., Mason, N. L., Briedé, J. J., Schreiber, R., Verheijen, M. C. T., Krauskopf, J., & Ramaekers, J. G. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.08.04.742737
Self-citationPotential Role of Psychedelics in the Treatment of Depressive Disorder
Wang, S., & Bahk, W.-M. (2026) · Springer eBooks · doi:10.1007/978-981-92-1331-3_12
O'Shea, A., Mason, N. L., Schreiber, R., Verheijen, M. C. T., Ramaekers, J. G., Briedé, J. J., & Krauskopf, J. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.08.04.742716
Self-citationMason, N. L., Mallaroni, P., Kuypers, K. P. C., de la Torre, R., Reckweg, J. T., Preller, K. H., & Ramaekers, J. G. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.08.04.742704
Self-citationKandilakis, C. L., & Papatheodoropoulos, C. (2026) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2026.111898
Language-associated brain representations covary with disruption of selfhood under psilocybinPreprint
Cooper, G., Stoliker, D., Delgado, S. V. A., Blackburne, G., Novelli, L., Green, D. W., Das, R., Razi, A., & Skipper, J. I. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.10.06.757069
AbouEich, H. K., Izadi, A., Lifshitz, J., Olson, D. E., & Gurkoff, G. G. (2026) · Journal of Neurotrauma · doi:10.1177/08977151261495030
Metadata
- Authors
- Mason, N. L., Kuypers, K. P. C., Müller, F., Reckweg, J., Tse, D. H. Y., Toennes, S. W., Hutten, N. R. P. W., Jansen, J. F. A., Stiers, P., Feilding, A., & Ramaekers, J. G.
- Affiliations
- Maastricht University (NL)
- University of Basel (CH)
- Goethe University Frankfurt (DE)
- Maastricht University Medical Centre (NL)
- Beckley Foundation (GB)
- Corresponding author
- Mason, N. L.
- Ramaekers, J. G.
- ORCID
- Venue
- Neuropsychopharmacology
- Published
- 2020-05-23
- Volume
- 45
- Issue
- 12
- Pages
- 2003-2011
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- PMC
- PMC7547711
- OpenAlex
- W3027590463
- Cited by
- 258
- References
- 102
- Citations by year
- 2026: 36 · 2025: 41 · 2024: 40 · 2023: 62 · 2022: 42 · 2021: 32 · 2020: 5
- FWCI
- 14.08
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Neuropsychopharmacology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Research Publications (Maastricht University) (submittedVersion, cc-by)
- Research Publications (Maastricht University) (submittedVersion, other-oa)
- Funders
- Beckley Foundation
- Topics
- Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Social Sciences › Psychology › Social Psychology › Paranormal Experiences and Beliefs
- Keywords
- psilocybin, glutamate, ego dissolution, self-experience, medial prefrontal cortex, hippocampus, subjective experience, psychedelics, depression, ultra-high field MRI
- MeSH terms
- Ego, Hallucinogens, Humans, Psilocybin, Solubility, Glutamic Acid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review